Davidson, A. L., Dressel, U., Norris, S., Canson, D. M., Glubb, D. M., Fortuno, C., . . . Ward, R. L. (2023). The clinical utility and costs of whole-genome sequencing to detect cancer susceptibility variants—a multi-site prospective cohort study. Genome medicine, 15(1), 1-16. https://doi.org/10.1186/s13073-023-01223-1
Chicago-Zitierstil (17. Ausg.)Davidson, Aimee L., et al. "The Clinical Utility and Costs of Whole-genome Sequencing to Detect Cancer Susceptibility Variants—a Multi-site Prospective Cohort Study." Genome Medicine 15, no. 1 (2023): 1-16. https://doi.org/10.1186/s13073-023-01223-1.
MLA-Zitierstil (9. Ausg.)Davidson, Aimee L., et al. "The Clinical Utility and Costs of Whole-genome Sequencing to Detect Cancer Susceptibility Variants—a Multi-site Prospective Cohort Study." Genome Medicine, vol. 15, no. 1, 2023, pp. 1-16, https://doi.org/10.1186/s13073-023-01223-1.